Librizzi Jamie, Flores Samuel, Morse Keith, Kelleher Kelly, Carter Jodi, Bode Ryan
Department of Pediatric Hospital Medicine, Phoenix Children's Hospital, Phoenix, Arizona; and
Department of Pediatric Hospital Medicine, Phoenix Children's Hospital, Phoenix, Arizona; and.
Hosp Pediatr. 2017 Jun;7(6):320-327. doi: 10.1542/hpeds.2016-0101.
Constipation is a common pediatric condition with a prevalence of 3% to 5% in children aged 4 to 17 years. Currently, there are no evidence-based guidelines for the management of pediatric patients hospitalized with constipation. The primary objective was to evaluate practice patterns and patient outcomes for the hospital management of functional constipation in US children's hospitals.
We conducted a multicenter, retrospective cohort study of children aged 0 to 18 years hospitalized for functional constipation from 2012 to 2014 by using the Pediatric Health Information System. Patients were included by using constipation and other related diagnoses as classified by . Patients with complex chronic conditions were excluded. Outcome measures included percentage of hospitalizations due to functional constipation, therapies used, length of stay, and 90-day readmission rates. Statistical analysis included means with 95% confidence intervals for individual hospital outcomes.
A total of 14 243 hospitalizations were included, representing 12 804 unique patients. The overall percentage of hospitalizations due to functional constipation was 0.65% (range: 0.19%-1.41%, < .0001). The percentage of patients receiving the following treatment during their hospitalization included: electrolyte laxatives: 40% to 96%; sodium phosphate enema: 0% to 64%; mineral oil enema: 0% to 61%; glycerin suppository: 0% to 37%; bisacodyl 0% to 47%; senna: 0% to 23%; and docusate 0% to 11%. Mean length of stay was 1.97 days (range: 1.31-2.73 days, < .0001). Mean 90-day readmission rate was 3.78% (range: 0.95%-7.53%, < .0001).
There is significant variation in practice patterns and clinical outcomes for pediatric patients hospitalized with functional constipation across US children's hospitals. Collaborative initiatives to adopt evidence-based best practices guidelines could help standardize the hospital management of pediatric functional constipation.
便秘是一种常见的儿科疾病,在4至17岁儿童中的患病率为3%至5%。目前,尚无针对因便秘住院的儿科患者管理的循证指南。主要目的是评估美国儿童医院对功能性便秘进行医院管理的实践模式和患者预后。
我们利用儿科健康信息系统,对2012年至2014年因功能性便秘住院的0至18岁儿童进行了一项多中心回顾性队列研究。根据[具体分类标准]中便秘及其他相关诊断纳入患者。排除患有复杂慢性病的患者。结局指标包括因功能性便秘住院的百分比、使用的治疗方法、住院时间和90天再入院率。统计分析包括各医院结局的均值及95%置信区间。
共纳入14243次住院病例,代表12804名不同患者。因功能性便秘住院的总体百分比为0.65%(范围:0.19% - 1.41%,P <.0001)。住院期间接受以下治疗的患者百分比包括:电解质泻药:40%至96%;磷酸钠灌肠剂:0%至64%;矿物油灌肠剂:0%至61%;甘油栓:0%至37%;比沙可啶:0%至47%;番泻叶:0%至23%;多库酯:0%至11%。平均住院时间为1.97天(范围:1.31 - 2.73天,P <.0001)。平均90天再入院率为3.78%(范围:0.95% - 7.53%,P <.0001)。
美国各儿童医院对因功能性便秘住院的儿科患者的实践模式和临床结局存在显著差异。采用循证最佳实践指南的合作倡议有助于规范儿科功能性便秘的医院管理。